Bio-Rad Laboratories BIO Clinical Diagnostics — Total Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's clinical diagnostics — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bio-Rad Laboratories's clinical diagnostics — total assets?
- Bio-Rad Laboratories (BIO) reported clinical diagnostics — total assets of $468.8M in Q1 2026.
- How has Bio-Rad Laboratories's clinical diagnostics — total assets changed year-over-year?
- Bio-Rad Laboratories's clinical diagnostics — total assets decreased by 2.7% year-over-year, from $482M to $468.8M.
- What does clinical diagnostics — total assets mean?
- The total value of all assets specifically identified and allocated to the Clinical Diagnostics segment, including inventory, property, plant, equipment, and goodwill. It represents the capital base utilized to generate segment revenue.